Valuation: TransMedics Group, Inc.

Market Cap 2.92B 2.57B 2.43B 2.21B 4.14B 280B 4.18B 29.2B 11.25B 143B 10.95B 10.71B 460B P/E 2026 *
61.4x
P/E 2027 * 38.6x
Enterprise Value 2.87B 2.54B 2.4B 2.18B 4.08B 276B 4.12B 28.8B 11.1B 141B 10.8B 10.56B 453B EV / Sales 2026 *
3.88x
EV / Sales 2027 * 3.17x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.83%
1 week-4.94%
Current month-2.56%
1 month-2.56%
3 months+24.51%
6 months-12.31%
Current year-32.02%
1 week 81.55
Extreme 81.55
86.38
1 month 79.23
Extreme 79.23
90.67
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 31/07/1998
Director of Finance/CFO 46 20/09/2026
Chief Operating Officer 43 01/02/2023
Director TitleAgeSince
Director/Board Member 57 31/07/1998
Chairman 81 31/12/2010
Director/Board Member 78 31/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Buy

Director

1,336 0.0039%
17/08/26 Don

Chairman

-18,000 0.0528%
10/07/26 Free

Chief Financial Officer

43,399 0.1273%
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%-4.94%-26.29%+56.69% 2.92B
+0.19%+2.27%+40.29%+37.24% 251B
-1.07%+0.91%+12.77%+4.60% 159B
-0.76%+2.74%-8.50%+38.73% 146B
+0.01%-1.62%-55.04%-16.88% 63.59B
-1.24%+0.10%+11.75%+25.63% 50.77B
-0.12%+5.53%+35.93%+57.31% 49.35B
-1.76%+2.07%-17.49%-21.01% 48.75B
+3.26%+6.28%-3.41%+43.04% 45.1B
+0.14%+5.47%+47.95%+63.97% 43.55B
Average -0.30%+2.14%+3.80%+28.93% 85.99B
Weighted average by Cap. -0.27%+3.03%+12.55%+26.34%

Financials

2026 *2027 *
Net sales 742M 655M 619M 562M 1.05B 71.17B 1.06B 7.43B 2.86B 36.34B 2.79B 2.72B 117B 875M 772M 730M 662M 1.24B 83.94B 1.25B 8.76B 3.38B 42.86B 3.28B 3.21B 138B
Net income 50.86M 44.88M 42.47M 38.51M 72.2M 4.88B 72.92M 509M 196M 2.49B 191M 187M 8.02B 88.06M 77.71M 73.53M 66.68M 125M 8.45B 126M 882M 340M 4.31B 331M 323M 13.89B
Net Debt -40.26M -35.53M -33.62M -30.49M -57.15M -3.86B -57.72M -403M -155M -1.97B -151M -148M -6.35B -146M -129M -122M -110M -207M -13.98B -209M -1.46B -562M -7.14B -547M -535M -22.97B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
30/09/26 US$82.58 -1.77% 148,095
29/09/26 US$84.07 +1.62% 440,203
28/09/26 US$82.73 -3.00% 422,561
25/09/26 US$85.29 +1.66% 696,739
24/09/26 US$83.90 -3.56% 623,710
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
84.07USD
Average target price
97.30USD
Spread / Average Target
+15.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock